Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

Active, not recruiting

• Conditions: Solid Tumors; Hematologic Malignancies

• Registration Number: NCT02457962
• Lead Sponsor: Mayo Clinic

Brief Summary

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04-23
• Study First Submitted: 2015-05-11
• Study First Submitted QC: 2015-05-27
• Study First Posted: 2015-05-29
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-15
• Last Update Posted: 2025-05-18
• Primary Completion: 2026-04
• Study Completion: 2026-04

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 15000

Inclusion Criteria

1. Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology
2. Radiation therapy for curative intent

Exclusion Criteria

None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
analyze acute and late toxicities using CTCAE 4.03	Patients will be followed for the duration of their life, an expected average of 20 years
analyze quality of life using LASA-3 and FACT-E	Patients will be followed for the duration of their life, an expected average of 20 years

Secondary Outcome Measures

Name	Time	Method
analyze local control through tumor assessments	Patients will be followed for the duration of their life, an expected average of 20 years
analyze survival by contacting patient and EMR (electronic medical record) review	Patients will be followed for the duration of their life, an expected average of 20 years

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Rochester, Minnesota, United States